Minnesota Medical Technologies Corporation, a United States-based medical device manufacturing company, has signed a contract with Sweden-based Wellspect Healthcare for the distribution of Minnesota Medical's faecal incontinence insert throughout Europe, it was reported on Wednesday.

This agreement grants Wellspect Healthcare the exclusive rights to distribute Minnesota Medical's innovative faecal incontinence insert device in markets across Europe under Wellspect's Navina brand.

David A Jonas, Minnesota Medical's CEO, said, 'We are pleased to announce this exciting, strategic partnership with Wellspect. This collaboration puts our innovative technology in the hands of one of the world's leading providers of continence care solutions. Wellspect has the infrastructure and relationships to immediately begin marketing and distributing this life changing product throughout Europe. Without question, this will accelerate our growth curve.'